Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
| Autor: | Joshipura, Deep, Alomran, Abdulaziz, Zancanaro, Pedro, Rosmarin, David |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology June 2018 78(6):1205-1207 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect